Hindustan Bio Sciences Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2015. For the quarter, the company reported total income from operations (net) of nil compared to INR 2.250 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 1.463 million compared to INR 1.056 million a year ago. Loss from ordinary activities before tax was INR 1.523 million compared to INR 1.124 million a year ago. Net loss for the period was INR 1.523 million or INR 0.15 per basic and diluted share compared to INR 1.124 million or INR 0.11 per basic and diluted share a year ago.

For the nine months, the company reported total income from operations (net) of INR 10.266 million compared to INR 5.957 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 0.736 million compared to INR 11.983 million a year ago. Loss from ordinary activities before tax was INR 0.932 million compared to INR 12.220 million a year ago. Net loss for the period was INR 12.220 million or INR 0.19 per basic and diluted share compared to INR 12.220 million or INR 1.19 per basic and diluted share a year ago.